66 results
Page 3 of 4
8-K
EX-99.1
3nx1wzox
26 Mar 20
NeuBase Therapeutics Reports Financial Results for the First Fiscal Quarter of 2020
4:06pm
8-K
EX-99.1
ef56j4u
9 Jan 20
NeuBase Therapeutics Reports Financial Results for Fiscal Year 2019
4:06pm
424B3
e2rheoc kq849z9fcfb3
23 Sep 19
Prospectus supplement
5:05pm
424B3
rkz8qx2e544o4l5p9
6 Jun 19
Prospectus supplement
5:15pm
S-4/A
o3gjq06rrtdo 0h
16 Apr 19
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4
508qgx7tpnq lq
8 Mar 19
Registration of securities issued in business combination transactions
5:12pm
8-K
EX-99.1
de3pls n1he
3 Jan 19
Entry into a Material Definitive Agreement
5:29pm
8-K
EX-99.2
hqqp2
3 Jan 19
Entry into a Material Definitive Agreement
5:29pm
425
EX-99.1
vwi18l1639qmlk
3 Jan 19
Business combination disclosure
5:28pm
425
EX-99.2
iq1x2r4q
3 Jan 19
Business combination disclosure
5:28pm
8-K
EX-99.1
zgyg0v8
14 Oct 14
Ohr Pharmaceutical Announces Successful End of Phase II Meeting with the FDA on Squalamine Eye Drops (OHR-102) in Wet AMD
12:00am
8-K
EX-99.1
wg68dk y8dmm92n0
29 May 12
Regulation FD Disclosure
12:00am
10-K
ypikb
13 Jan 09
Annual report
12:00am
8-K
nulh klcs
5 Apr 07
Completion of Acquisition or Disposition of Assets
12:00am